Loading chat...
NJ A1405
Bill
Status
1/9/2024
Primary Sponsor
Shama Haider
Click for details
AI Summary
-
Pharmacists are prohibited from interchanging any anti-epileptic drug or formulation (brand to generic, generic to brand, or between manufacturers) for treating seizures without prior notification and signed informed consent from both the prescribing physician and the patient (or parent, guardian, or spouse)
-
"Interchange" encompasses substituting generic for brand, brand for generic, different generic manufacturers, different formulations, or different anti-epileptic products than originally prescribed
-
The bill addresses concerns that small variations in drug concentrations between FDA-equivalent rated medications can cause toxic effects or breakthrough seizures in epilepsy patients
-
Takes effect on the first day of the second month following enactment
-
Supplements existing pharmacy law (P.L.1977, c.240) governing drug substitution practices
Legislative Description
Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.
Health
Last Action
Introduced, Referred to Assembly Health Committee
1/9/2024